Table 2. Pathologic data.
RRP (n=99) | RALP (n=223) | p value | ||
---|---|---|---|---|
Pathologic stage | 0.634 | |||
T2 | 61(61.6) | 129 (57.8) | ||
T3a | 26 (26.3) | 65 (29.1) | ||
T3b | 12 (12.1) | 26 (26.3) | ||
T4 | 0 (0) | 3 (1.3) | ||
Pathologic Gleason score | 0.744 | |||
6 | 33 (33.3) | 86 (38.6) | ||
7 | 37 (37.4) | 80 (35.9) | ||
8 | 24 (24.2) | 42 (18.8) | ||
9 | 4 (4.0) | 13 (5.8) | ||
10 | 1 (1.0) | 2 (1.0) | ||
Positive surgical margin (%) | 30/99 (30.3) | 83/223 (37.2) | 0.230 | |
Focal/extensive | 13/17 | 35/48 | 0.484 | |
Biochemical recurrence (%) | 7 (3.2) | 2 (2.0) | 0.574 |
Mean follow up duration: 31.4±10.3 months